0001104659-22-091357.txt : 20220815 0001104659-22-091357.hdr.sgml : 20220815 20220815173729 ACCESSION NUMBER: 0001104659-22-091357 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220815 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220815 DATE AS OF CHANGE: 20220815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XpresSpa Group, Inc. CENTRAL INDEX KEY: 0001410428 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PERSONAL SERVICES [7200] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34785 FILM NUMBER: 221167010 BUSINESS ADDRESS: STREET 1: 254 WEST 31ST STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (212) 309-7549 MAIL ADDRESS: STREET 1: 254 WEST 31ST STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Form Holdings, Inc. DATE OF NAME CHANGE: 20180102 FORMER COMPANY: FORMER CONFORMED NAME: XpresSpa Group, Inc. DATE OF NAME CHANGE: 20180102 FORMER COMPANY: FORMER CONFORMED NAME: FORM Holdings Corp. DATE OF NAME CHANGE: 20160509 8-K 1 tm2223496d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(D) of the Securities Exchange Act Of 1934

Date of report (Date of earliest event reported): August 15, 2022

XpresSpa Group, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

001-34785		20-4988129
(Commission File Number)		(IRS Employer Identification No.)

254 West 31^st Street, 11^thFloor, New York, New York		10001
(Address of Principal Executive Offices)		(Zip Code)

(212) 309-7549

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

	¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

	¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

	¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: [ ]

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.01 per share		XSPA		The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02

Results of Operations and Financial Condition.

Attached hereto as Exhibit 99.1 is a copy of a press release of XpresSpa Group, Inc., dated August 15, 2022, announcing certain operating results for the fiscal quarter ended June 30, 2022. The information in the press release is incorporated by reference into this Item 2.02 of this Current Report on Form 8-K.

In accordance with General Instruction B.2 on Form 8-K, the information set forth under this Item 2.02 of this Current Report on Form 8-K, including the press release attached to attached as an exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference.

Forward-Looking Statements

The press release includes forward-looking statements, which may be identified by words such as “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” or the negative of such terms, or other comparable terminology. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from the forward-looking statements contained herein. The forward-looking statements in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including, but not limited to, the risks and uncertainties and other factors discussed from time to time in the Company’s filings with the Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and proxy statements, registration statement and other documents filed by the Company from time to time with the SEC. The Company expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

99.1 Press Release, dated August 15, 2022

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	XpresSpa Group, Inc.

Date: August 15, 2022	By:	/s/ Scott R. Milford
	Name:	Scott R. Milford
	Title:	Chief Executive Officer

EX-99.1 2 tm2223496d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

XpresSpa Group Reports Second Quarter 2022 Results

XpresCheck, through its Partnership with Ginkgo Bioworks, Awarded

New CDC Biosurveillance Contract Valued Up To $61 Million

Leading Health and Wellness Provider for ‘People on the Go’

Demonstrated Success Executing Against Strategic Imperatives

Creating A Strong Retail Engine including Deploying Expanded Product Offering, New Wellness Technology, and Refreshed Look

Expansion Internationally into Istanbul Airport

Webcast and Conference Call Scheduled for 4:30 p.m. ET Today

NEW YORK, August 15, 2022 -- XpresSpa Group, Inc. (Nasdaq: XSPA), a travel health and wellness company, today reported that it has filed financial results on Form 10-Q for the second quarter ending June 30, 2022.

Strategic Overview

XpresSpa Group continues to make steady progress on executing against its four core transformational imperatives:

•

Refreshing its business in the airport to attract more customers

•

Creating and executing a completely new retail strategy to not only drive more foot traffic into our airport locations but also augment our on-line presence

•

Adding new customers through revenue-accretive acquisition and the deployment of a B2B wellness product outside the airport

•

Reducing infrastructure cost to better leverage capital

“We are committed to delivering on our four core imperatives and we’re enthusiastic about the measurable progress we’ve made during the last few months,” Scott Milford, XpresSpa Group’s Chief Executive Officer, stated, “We have 26 Spas currently open globally with another five scheduled to open in the third quarter of this year, including our first location in Turkey’s Istanbul Airport. Our Spa performance continues to improve as more travelers return to the air. To support our continued growth, we’re innovating to create a holistic wellness experience for our guests with new services, add-ons, better tech and expanded product offerings. Furthermore, we are creating and executing a completely new retail strategy to drive more foot traffic into our airport locations as well as to our on-line platform. Looking ahead, we’re planning to refresh the look and appearance of our Spa locations later this year and extending into 2023, and we also plan to open our third Treat location in Salt Lake City, Utah in late Q3.”

XpresSpa Group Reports Second Quarter 2022 Results

Page 2

“In addition to creating a strong retail engine, we remain focused on optimizing our available capital and organizing our business to be able to manage sustainable growth in the future. This includes embracing a lean and agile approach to managing costs in our existing business, while also ensuring we can scale XpresSpa Group's growth in a responsible manner that drives shareholder value.”

Mr. Milford added, “XpresSpa Group is also extremely pleased to announce that XpresCheck, through its partnership with Ginkgo Bioworks, has been awarded a new contract worth as much as $61 million to support the Centers for Disease Control and Prevention’s (CDC) expanded traveler-based genomic surveillance program for SARS-CoV-2, the virus that causes COVID-19. Building on a long-standing relationship with the CDC and Ginkgo Bioworks, the renewed traveler-based surveillance partnership is expected to leverage a variety of sampling modalities, including individual testing, pooled testing, wastewater testing, and a variety of genomic sequencing approaches. This contract is a significant milestone for XpresCheck, and I am proud of the Company’s role in helping the U.S. prepare and safeguard against future potential virologic outbreaks.”

Second Quarter Business Update

XpresCheck®

XpresSpa Group’s XpresTest, Inc. subsidiary (“XpresCheck”) provides medical diagnostic testing services, including COVID-19 testing for its customers. As of today, there are 15 XpresCheck locations operating in 12 airports.

In late 2021, XpresCheck began conducting bio surveillance monitoring, aimed at identifying existing and new SARS-CoV-2 variants, in collaboration with the CDC and Ginkgo Bioworks at four major U.S. airports (JFK International Airport, Newark Liberty International Airport, San Francisco International Airport, and Hartsfield-Jackson Atlanta International Airport). During the second quarter, the Company recognized $1.9 million of revenue related to this collaboration.

XpresSpa Group Reports Second Quarter 2022 Results

Page 3

As expected, as countries continued to relax their testing requirements, testing volumes at our XpresCheck locations decreased as we progressed through the second quarter.

The Company believes that a strong biosafety program is critical to the control of SARS-CoV-2, or any other potential virus, and remains focused on supporting this invaluable national effort. That said, based on the evolution of testing globally, and the creation of longer term biosurveillance efforts coupled with the current performance of its XpresCheck segment, the Company is in the process of laying out a plan to close unprofitable XpresCheck locations without compromising its biosurveillance apparatus.

XpresSpa®

There are currently 20 operating XpresSpa domestic locations, including two franchise locations, with another five locations scheduled to open in the third quarter. Most of the domestic XpresSpa locations are back to being open 7 days a week, which has improved labor productivity.

The Company, which is seeing renewed interest in wellness services among travelers along with a willingness to spend additional dollars on products and services that will improve their well-being while they travel, is executing a new retail strategy to drive more foot traffic into its airport locations and augment its on-line presence. This includes bringing new technologies and trends, including new tech forward equipment, adding new SKUs in-store and on-line, as well as deploying plans to refresh the look and appearance of some XpresSpa locations beginning later this year and extending into 2023.

Internationally, there are also 6 XpresSpa locations currently operating. These consist of 3 at Dubai International Airport in the UAE and 3 at Schiphol Amsterdam Airport in the Netherlands. The Company recently announced plans to open a XpresSpa location in Istanbul Airport in Turkey beginning in September 2022. This is the first of 5 new XpresSpa locations expected to open at Istanbul Airport by the end of 2022. This expansion will allow XpresSpa Group the opportunity to further leverage its expertise in providing premium wellness services to more international passengers who appreciate health and wellness services and are willing to spend more in pursuit of their well-being.

XpresSpa Group Reports Second Quarter 2022 Results

Page 4

Treat™

Treat is XpresSpa Group’s travel, health and wellness brand which transforms the way people access care through a suite of health and wellness services, as supported by an integrated digital platform.

Treat’s on-site centers are currently located at JFK International Airport in New York and at Phoenix Sky Harbor International Airport in Arizona. In late Q3, the Company is planning to open a third Treat location at Salt Lake City International Airport in Utah.

On the ground teams provide travel-related diagnostic testing for virus, cold, flu and other illnesses as well as hydration therapy, IV Drips, and vitamin injections. Travelers can purchase time blocks to use available wellness rooms to engage in interactive services like self-guided yoga, meditation and low impact weight exercises, or to relax and unplug from the hectic pace of the airport and renew themselves before or after their trip.

We will continue to evaluate the Treat segment as an opportunity for innovation and growth. We will also use the opportunity to evolve and align spa services with some of the more popular Treat offerings to further integrate these businesses.

HyperPointe

In January 2022, we announced and closed on the acquisition of GCG Connect, LLC d/b/a HyperPointe. HyperPointe is a leading digital healthcare and data analytics relationship marketing agency, servicing the global healthcare and pharmaceutical industry. HyperPointe has significant experience in patient and healthcare professional marketing and deep technological experience with CXM (customer experience management) and data analytics.

Since June 2020, HyperPointe’s management team and suite of services and technology have been used to develop and deploy the technological infrastructure needed to scale the growth of our XpresCheck business. HyperPointe’s experience in this space continues to serve the XpresCheck business and will play a critical role in the expansion of ongoing biosurveillance efforts created by the new contract with Ginkgo Bioworks and the CDC.

XpresSpa Group Reports Second Quarter 2022 Results

Page 5

Share Repurchase Program

On May 20, 2022, the Company announced that its Board of Directors authorized a 10 million share increase to its existing stock repurchase program, which was extended through September 15, 2023. The original stock repurchase program, announced in August 2021, was for 15 million shares, and there were approximately 3.2 million shares remaining under that original authorization as of the date of such increase.

During the second quarter of 2022, the Company continued to execute on its share repurchase program, repurchasing 1.3 million shares at average cost of $0.76 per share, for a total of $1.0 million.

Since initiating the stock repurchase plan on August 31, 2021, the Company has repurchased approximately 13.2 million shares through June 30, 2022, for total consideration of approximately $19.9 million. As of August 15, 2022, there are 11.8 million shares that may be purchased under the current authorization.

Based upon the current share price, which management believes is substantially undervalued, the intention is to repurchase additional shares, when possible, subject to the limitations of blackout restrictions.

Liquidity and Financial Condition

As of June 30, 2022, the Company had cash and cash equivalents, excluding restricted cash, of $71.1 million and no long-term debt.

Summary of Second Quarter 2022 Financial Results

Total revenue during the three months ended June 30, 2022, was $13.6 million compared to $9.1 million in the corresponding period in 2021. The revenue for the quarter primarily consisted of $7.4 million from XpresCheck locations, as well as $3.7 million in revenue from our reopened XpresSpa locations and Treat wellness centers, and $0.7 million from HyperPointe.

Cost of Sales

Cost of sales increased to $12.4 million from $7.7 million in the prior year second quarter primarily due to the increased costs to operate the XpresCheck locations, and the reopening of certain XpresSpa locations that were temporarily closed during the second quarter of 2021.

XpresSpa Group Reports Second Quarter 2022 Results

Page 6

General and Administrative Expenses

General and administrative expenses were $7.6 million compared to $4.6 million for the year ago comparable period. The increase was primarily due to functional costs associated with the operations of XpresCheck and Treat wellness centers, XpresSpa locations, and the newly acquired HyperPointe segment.

Income from Operations

Loss from operations was $7.8 million compared to $4.2 million in the prior year second quarter.

Net Income Attributable to Common Shareholders

Net loss attributable to common shareholders was $7.9 million compared to $4.5 million in the prior year second quarter.

XpresCheck Operational Metrics

Total Patients by Quarter

Q1 2021	37,589
Q2 2021	92,415
Q3 2021	113,212
Q4 2021	104,805
Q1 2022	78,976
Q2 2022	30,601

Total Rapid Test (Antigen and PCR) / Percent of Total Patients by Quarter

Q1 2021	27,651	74%
Q2 2021	75,788	82%
Q3 2021	110,376	97%
Q4 2021	103,000	98%
Q1 2022	78,524	99%
Q2 2022	30,746	100%

XpresSpa Group Reports Second Quarter 2022 Results

Page 7

Rapid PCR Tests / Percent of Total Rapid Tests by Quarter

Q1 2021	114	0%
Q2 2021	32,382	43%
Q3 2021	74,090	67%
Q4 2021	101,526	99%
Q1 2022	78,261	99%
Q2 2022	30,690	100%

Non-GAAP Financial Metrics

Adjusted EBITDA

On a non-GAAP basis, Adjusted EBITDA loss was $5.0 million during the second quarter 2022, compared to Adjusted EBITDA loss of $2.9 million in the prior year second quarter.

We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization expense, non-cash charges, and stock-based compensation expense.

We consider Adjusted EBITDA to be an important indicator for the performance of our operating business, XpresCheck. In particular, we believe that it is useful for analysts and investors to understand that Adjusted EBITDA excludes certain transactions not related to core cash operating activities, which are primarily related to XpresCheck. We believe that excluding these transactions allows investors to meaningfully analyze the performance of core cash operations.

A reconciliation of operating loss presented in accordance with GAAP for the three-month periods ended June 30, 2022 and 2021 to Adjusted EBITDA (loss) is presented in the table below:

		Three months ended June 30,
		2022				2021
Income (loss) from operations		$	(7,767	)			(4,201	)
Add back:
Depreciation and amortization			1,501				946
Impairment/disposal of assets			(52	)			---
Stock-based compensation expense			1,320				328
Adjusted EBITDA /(Loss)		$	(4,998	)			(2,927	)

XpresSpa Group Reports Second Quarter 2022 Results

Page 8

Webcast and Conference Call Today

XpresSpa Group host a webcast and conference call at 4:30 p.m. Eastern Time today. We encourage investors and interested parties to listen via webcast as there is a limited capacity to access the conference call by dialing 1-412-902-0130. To submit a question, please email ir@xpresspagroup.com.

The live and later archived webcast can be accessed from the Investor Relations section of the Company’s website at http://xpresspagroup.com. Visitors to the website should select the “Investors” tab and navigate to the “Events” link to access the webcast.

About XpresSpa Group, Inc.

XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading global health and wellness holding company operating four brands: XpresCheck®, XpresSpa®, Treat™ and HyperPointe.

·

XpresSpa is a leading airport retailer of wellness services and related products, with 26 locations in 13 airports globally.

·

Treat is a travel health and wellness brand that is providing on-demand access to healthcare through technology and personalized services, including two domestic airport locations.

·

XpresCheck is a leading provider of COVID-19 screening and diagnostic testing with 15 locations in 12 domestic airports. XpresCheck is also partnered with Ginkgo Bioworks, in collaboration with the CDC, conducting biosurveillance monitoring in its airport locations to identify existing and new SARS-CoV-2 variants.

·

HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.

To learn more about XpresCheck, visit: www.XpresCheck.com

To learn more about XpresSpa, visit www.XpresSpa.com

To learn more about Treat, visit: www.Treat.com

To learn more about HyperPointe, visit: www.HyperPointe.com

Twitter: @xprescheck and Instagram: @realxprescheck

Twitter: @XpresSpa and Instagram: @XpresSpa

Twitter: @Treat_Care and Instagram: @treat_care

XpresSpa Group Reports Second Quarter 2022 Results

Page 9

Forward-Looking Statements

This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events are based upon information available to XpresSpa Group as of today's date and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in XpresSpa Group’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other Securities and Exchange Commission filings. All subsequent written and oral forward-looking statements concerning XpresSpa Group, or other matters and attributable to XpresSpa Group or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XpresSpa Group does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.

Investor Relations

Joseph Calabrese

MWW

ir@xpresspagroup.com

Media

Heather Tidwell

MWW

htidwell@mww.com

EX-101.SCH 3 xspa-20220815.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 xspa-20220815_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 xspa-20220815_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2223496d1_ex99-1img001.jpg GRAPHIC begin 644 tm2223496d1_ex99-1img001.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	Aug. 15, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Aug. 15, 2022
Entity File Number	001-34785
Entity Registrant Name	XpresSpa Group, Inc.
Entity Central Index Key	0001410428
Entity Tax Identification Number	20-4988129
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	254 West 31st Street
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	212
Local Phone Number	309-7549
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	XSPA
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

XML 8 tm2223496d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001410428 2022-08-15 2022-08-15 iso4217:USD shares iso4217:USD shares 0001410428 false 8-K 2022-08-15 XpresSpa Group, Inc. DE 001-34785 20-4988129 254 West 31st Street 11th Floor New York NY 10001 212 309-7549 false false false false Common Stock, par value $0.01 per share XSPA NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://vringo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2223496d1_8k.htm tm2223496d1_ex99-1.htm xspa-20220815.xsd xspa-20220815_lab.xml xspa-20220815_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2223496d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm2223496d1_8k.htm" ] }, "labelLink": { "local": [ "xspa-20220815_lab.xml" ] }, "presentationLink": { "local": [ "xspa-20220815_pre.xml" ] }, "schema": { "local": [ "xspa-20220815.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "xspa", "nsuri": "http://vringo.com/20220815", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2223496d1_8k.htm", "contextRef": "From2022-08-15to2022-08-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://vringo.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2223496d1_8k.htm", "contextRef": "From2022-08-15to2022-08-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://vringo.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001104659-22-091357-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-091357-xbrl.zip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